BioProcess Insider - News BioProcess International

We are in the ‘golden age for the CDMO space,’ says Thermo Fisher

With over 75% of new molecules coming from small and emerging biotech, opportunities for third-party manufacturers have never been so large says Thermo Fisher CEO Marc Casper. Thermo Fisher jumped into the third-party biomanufacturing space in August 2017 through its acquisition of contract dev ...

Genentech on tech transfer: ‘Small volumes are all a bit new to us’
Genentech says it is looking to disruptive technologies for a fast and agile response to capacity demands as its portfolio evolves away from larg ...
Access to smart money a key life science growth driver, Dynamk
Bioprocess executives moving to the financial sector shows a strong desire for continued investment in the life sciences space, says Daniella Kra ...
Thermo Fisher injecting $150m in Patheon fill & finish plants
Two facilities in Italy and a site in Greenville, North Carolina are being expanded to support demand for biologics aseptic liquid and lyophilize ...
Lonza’s POC CAR-T tech: Out with the cleanroom, in with the Cocoon
Lonza will provide its point-of-care (POC) Cocoon cell therapy platform to the Sheba Medical Center in Israel to provide automated and closed CAR ...

Covering the whole development process for the global biotechnology industry

More From BioProcess Insider

Recent Tweets

Recent Tweets

Trending